FSTX - F-star Therapeutics Inc. (FSTX) CEO Eliot Forster on Q2 2021 Results - Earnings Call Transcript
F-star Therapeutics, Inc. (FSTX) Q2 2021 Earnings Conference Call August 12, 2021, 09:00 AM ET Company Participants Lindsey Trickett - VP of IR Eliot Forster - CEO Darlene Deptula-Hicks - CFO Conference Call Participants Daina Graybosch - SVB Leerink Matt Phipps - William Blair Hartaj Singh - Oppenheimer Yale Jen - Laidlaw & Company Patrick Trucchio - H.C. Wainwright Justin Walsh - B. Riley Securities Presentation Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the F-star Therapeutics, Incorporated Second Quarter 2021 Earnings Call and Corporate Update. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference will be recorded and available for replay. I would now like to introduce you to Lindsey Trickett, VP of Investor Relations for F-star. Please go ahead. Lindsey Trickett Hi, and
For further details see:
F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q2 2021 Results - Earnings Call Transcript